Published in Medical Devices and Surgical Technology Week, October 1st, 2006
In a recently published article, scientists in the Netherlands conducted a study "to evaluate the value of clinical trials on intratympanic steroid therapy in Meniere's disease (MD), idiopathic sudden sensorineural hearing loss (ISSNHL) and rapidly progressive sensorineural hearing loss (RPSNHL). Medline and Pubmed databases from 1966 to present were searched for clinical studies on intra- or transtympanic (cortico)steroid therapy of MD, ISSNHL and RPSNHL."
"Results were cross-checked with additional databases to obtain a complete data set. Clinical trials were evaluated on the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Devices and Surgical Technology Week